Has Reetuparna Bhattacharjee received payments from drug or device companies?

Yes. Drug and device makers reported $2,484 in general payments to Reetuparna Bhattacharjee across 86 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Reetuparna Bhattacharjee did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Reetuparna Bhattacharjee come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Reetuparna Bhattacharjee

Internal Medicine · Paterson, NJNPI 1700269461

Payments from drug & device makers

$2,484in general payments, 2019–2025

Across 86 payments — averaging $28.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novo Nordisk$570
Boehringer Ingelheim$500
GSK$258
Dexcom, Inc.$204
Lilly USA, LLC$174
Bayer$122
plus $654 from 15 others

What the payments were for

Food & beverage$2,484100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novo Nordisk	20	$570
Boehringer Ingelheim	6	$500
GSK	10	$258
Dexcom, Inc.	2	$204
Lilly USA, LLC	11	$174
Bayer	6	$122
Portola Pharmaceuticals, LLC	1	$106
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	2	$102
Merck	6	$89
Novartis	6	$85
AstraZeneca	3	$41
Exact Sciences	1	$32
Amgen	2	$31
Amarin Pharma, Inc.	2	$30
Johnson & Johnson	2	$27
Hologic Sales And Service, LLC	1	$27
Bristol Myers Squibb	1	$19
Argenx US, Inc.	1	$18
Pfizer	1	$17
Genentech USA, Inc.	1	$16
E.r. Squibb & Sons, L.L.C.	1	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,484 in reported general payments places this provider in the 80th percentile of 4,032 internal medicine providers in New Jersey.

See all internal medicine providers in New Jersey →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
JardianceEmpagliflozin	87	$106,735
OzempicSemaglutide	58	$60,810
EliquisApixaban	54	$46,983
FarxigaDapagliflozin Propanediol	39	$38,428
JanuviaSitagliptin Phosphate	29	$30,631
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	31	$23,435
EntrestoSacubitril/Valsartan	19	$19,937
Breo ElliptaFluticasone/Vilanterol	34	$14,300
MounjaroTirzepatide	13	$13,837
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog	29	$9,352
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	52	$6,083
Albuterol Sulfate HfaAlbuterol Sulfate	199	$4,908
SymbicortBudesonide/Formoterol Fumarate	15	$3,278
Fluticasone-SalmeterolFluticasone Propion/Salmeterol	20	$3,106
Atorvastatin Calcium	366	$2,366

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Boehringer IngelheimJardiance	$500	$106,73587 claims
Novo NordiskOzempic	$570	$60,81058 claims
PfizerEliquis	$17	$46,98354 claims
AstraZenecaFarxiga, Symbicort	$41	$41,70654 claims
GSKTrelegy Ellipta, Breo Ellipta	$258	$37,73465 claims
MerckJanuvia	$89	$30,63129 claims
NovartisEntresto	$85	$19,93719 claims
Lilly USA, LLCMounjaro	$174	$13,83713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,032 internal medicine providers in New Jersey.

Other internal medicine in Paterson

Sanjiv SharmaToms River$33.9M
Jeffrey CarsonNew Brunswick$13.8M
Samer HaddadHamilton$6.8M
Magdy ShenoudaWall$3.7M
Samar HameedLivingston$3.6M
Jane RohlfTrenton$2.7M
Mohammed NisarEdison$2.6M
Michael CasserNew Milford$2.2M
Sumitha ReddyHamilton$2M
Helio PedroNewark$1.8M

See the full list for New Jersey →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →